Bladex Inc., a multinational bank, engages in financing of foreign trade and economic integration in Latin America and the Caribbean. It operates through Commercial and Treasury segments. The company accepts deposits. It also offers products and services, such as origination of bilateral short- and medium-term loans, structured and syndicated credits, and loan commitments; financial guarantee contracts, including issued and confirmed letters of credit, stand-by letters of credit, guarantees covering commercial risk, and other assets of customers' liabilities under acceptances; and co-financing arrangements, underwriting of syndicated credit facilities, structured trade financing in the form of factoring and vendor financing, and financial leasing. In addition, the company is involved in investment management activities comprising securities at fair value through other comprehensive income and amortized cost. It serves financial institutions, corporations, sovereigns, and state-owned entities. The company was formerly known as Banco Latinoamericano de Comercio Exterior, S. A. and changed its name to Bladex Inc. in June 2026. Bladex Inc. was founded in 1975 and is headquartered in Panama City, the Republic of Panama.…
Bladex: 3 Key Takeaways for Long-Term Investors
Bladex (NYSE: BLX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector.
The shares were at 46.90 USD on 20 November 2026, up 11.1% over 52 weeks. Its 52-week range is 42.29 USD to 63.20 USD: the price is 25.8% below the high and 10.9% above the low.
At a market capitalisation of 1.75B USD, it trades at 7.7 times trailing earnings and 6.7 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a discount of 25% for BLX. It pays a dividend yielding 5.67% (it pays out 44% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
Bladex reports return on equity of 13.5%, an operating margin of 71.9% and revenue up 16.3% year over year.
Its debt exceeds its cash by 6.21B USD, a debt-to-equity ratio of 2.41. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock; their mean price target of 69.65 USD is 48.5% above the current price. The next earnings report is expected on 11 February 2027.